Literature DB >> 19694908

Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.

Tohru Kitada1, Youren Tong, Clement A Gautier, Jie Shen.   

Abstract

Recessively inherited loss-of-function mutations in the parkin, DJ-1, or PINK1 gene are linked to familial cases of early-onset Parkinson's diseases (PD), and heterozygous mutations are associated with increased incidence of late-onset PD. We previously reported that single knockout mice lacking Parkin, DJ-1, or PINK1 exhibited no nigral degeneration, even though evoked dopamine release from nigrostriatal terminals was reduced and striatal synaptic plasticity was impaired. In this study, we tested whether inactivation of all three recessive PD genes, each of which was required for nigral neuron survival in the aging human brain, resulted in nigral degeneration during the lifespan of mice. Surprisingly, we found that triple knockout mice lacking Parkin, DJ-1, and PINK1 have normal morphology and numbers of dopaminergic and noradrenergic neurons in the substantia nigra and locus coeruleus, respectively, at the ages of 3, 16, and 24 months. Interestingly, levels of striatal dopamine in triple knockout mice were normal at 16 months of age but increased at 24 months. These results demonstrate that inactivation of all three recessive PD genes is insufficient to cause significant nigral degeneration within the lifespan of mice, suggesting that these genes may be protective rather than essential for the survival of dopaminergic neurons during the aging process. These findings also support the notion that mammalian Parkin and PINK1 may function in the same genetic pathway as in Drosophila.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694908      PMCID: PMC2952933          DOI: 10.1111/j.1471-4159.2009.06350.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

1.  Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.

Authors:  Matthew S Goldberg; Antonio Pisani; Marian Haburcak; Timothy A Vortherms; Tohru Kitada; Cinzia Costa; Youren Tong; Giuseppina Martella; Anne Tscherter; Andrea Martins; Giorgio Bernardi; Bryan L Roth; Emmanuel N Pothos; Paolo Calabresi; Jie Shen
Journal:  Neuron       Date:  2005-02-17       Impact factor: 17.173

2.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.

Authors:  D C German; C L Liang; K F Manaye; K Lane; P K Sonsalla
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

5.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

6.  Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.

Authors:  Jean-Michel Itier; Pablo Ibanez; Maria Angeles Mena; Nacer Abbas; Charles Cohen-Salmon; Georg Andrees Bohme; Michel Laville; Jeremy Pratt; Olga Corti; Laurent Pradier; Gwenaelle Ret; Chantal Joubert; Magali Periquet; Francisco Araujo; Julia Negroni; Maria Jose Casarejos; Santiago Canals; Rosa Solano; Alba Serrano; Eva Gallego; Marina Sanchez; Patrice Denefle; Jesus Benavides; Gunter Tremp; Thomas A Rooney; Alexis Brice; Justo Garcia de Yebenes
Journal:  Hum Mol Genet       Date:  2003-07-22       Impact factor: 6.150

7.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

8.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

9.  Familial Parkinsonism with digenic parkin and PINK1 mutations.

Authors:  Manabu Funayama; Yuanzhe Li; Tak-Hong Tsoi; Ching-Wan Lam; Takekazu Ohi; Shogo Yazawa; Eiichiro Uyama; Ruth Djaldetti; Eldad Melamed; Hiroyo Yoshino; Yoko Imamichi; Hiroshi Takashima; Kenya Nishioka; Kenichi Sato; Hiroyuki Tomiyama; Shin-Ichiro Kubo; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

10.  PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Authors:  Alison Wood-Kaczmar; Sonia Gandhi; Zhi Yao; Andrey Y Abramov; Andrey S Y Abramov; Erik A Miljan; Gregory Keen; Lee Stanyer; Iain Hargreaves; Kristina Klupsch; Emma Deas; Julian Downward; Louise Mansfield; Parmjit Jat; Joanne Taylor; Simon Heales; Michael R Duchen; David Latchman; Sarah J Tabrizi; Nicholas W Wood
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  90 in total

Review 1.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder.

Authors:  Yuzuru Imai; Bingwei Lu
Journal:  Curr Opin Neurobiol       Date:  2011-11-01       Impact factor: 6.627

Review 2.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 3.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

5.  Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.

Authors:  Lianteng Zhi; Qi Qin; Tanziyah Muqeem; Erin L Seifert; Wencheng Liu; Sushuang Zheng; Chenjian Li; Hui Zhang
Journal:  Neurobiol Aging       Date:  2018-11-02       Impact factor: 4.673

Review 6.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

Review 7.  Autophagy and human diseases.

Authors:  Peidu Jiang; Noboru Mizushima
Journal:  Cell Res       Date:  2013-12-10       Impact factor: 25.617

Review 8.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

9.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

Review 10.  The PINK1/Parkin pathway: a mitochondrial quality control system?

Authors:  Alexander J Whitworth; Leo J Pallanck
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.